Buformin concentrations in a case of fatal lactic acidosis

[1]  J. Cyran,et al.  [Lactacidosis in biguanide therapy: diagnosis and therapy. 4 cases compared to 179 cases in the world literature]. , 1978, Schweizerische medizinische Wochenschrift.

[2]  E. Ritz,et al.  Lactat-Azidose — Eine mögliche Komplikation der Buformin-Therapie , 1978, Klinische Wochenschrift.

[3]  K. Irsigler,et al.  [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)]. , 1978, Wiener Klinische Wochenschrift.

[4]  M. Eggstein,et al.  Lactic acidosis in biguanide-treated diabetics , 1978, Diabetologia.

[5]  K. Schöffling,et al.  Hämodialyse bei der Behandlung der biguanid-induzierten Lactacidose , 1978 .

[6]  R. Ritz,et al.  [10 cases of lactic acidosis during biguanide therapy (buformin and phenformin)]. , 1976, Schweizerische medizinische Wochenschrift.

[7]  P. Bottermann,et al.  [Investigations of the mode action of buformin using a 3H-labelled glucose in people with a healthy metabolism (author's transl)]. , 1976, Medizinische Klinik.

[8]  C. Baerlocher,et al.  Butylbiguanide concentration in plasma, liver, and intestine after intravenous and oral administration to man , 1974, European Journal of Clinical Pharmacology.

[9]  R. Beckmann,et al.  Evaluation of a sustained release form of the oral antidiabetic butylbiguanide (Silubin® retard) , 1971, European Journal of Clinical Pharmacology.

[10]  R. W. Myers,et al.  Effects of acute lactic acidosis on left ventricular performance. , 1968, The American journal of physiology.

[11]  M. N. Levy,et al.  Effects of changes of pH and of carbon dioxide tension on left ventricular performance. , 1967, The American journal of physiology.

[12]  R. Maes,et al.  A Specific Method for the Analysis of Buformin in Pre- and Post- Mortem Human Material , 1980 .